RARA and cancer: We then confirmed the computationally predicted differential binding of the top CL1-specific TF, RARα, at chr11:68,043,640–68,043,657 (GRCh38/hg38) in the promoter of TCIRG1, a gene that has a function in bone remodeling and cancer metastasis16.